As discussed in Note 1, the Company made corrections to the consolidated financial statements for periods ended December 31, 2022, January 1, 2022 and the quarterly periods of 2023. A summary of the corrections related to prior periods presented are as follows (tables may not foot or cross foot due to rounding):


Condensed Consolidated Statement of Operations
April 22, 2023
	Sixteen Weeks Ended
	As Previously Reported		Adjustments		As Corrected
Cost of sales	$	1,946,931	$	8,735	$	1,955,666
Gross profit	1,470,663		(8,735)		1,461,928
Selling, general and administrative expenses	1,380,664		(16,674)		1,363,990
Operating income	89,999		7,939		97,938





Income before provision for income taxes	59,607		7,939		67,546
Provision for income taxes	16,956		2,267		19,223
Net income	$	42,651	$	5,672	$	48,323

Basic earnings per share	$	0.72	$	0.09	$	0.81


Diluted earnings per common share	$	0.72	$	0.09	$	0.81


Condensed Consolidated Statement of Comprehensive Income
April 22, 2023
	Sixteen Weeks Ended
	As Previously Reported		Adjustments		As Corrected
Net income	$	42,651	$	5,672	$	48,323
Currency translation adjustments	591		(24)		567
Total other comprehensive loss	788		(24)		764
Comprehensive income	$	43,439	$	5,648	$	49,087


Condensed Consolidated Statements of Changes in Stockholders’ Equity
Sixteen Weeks Ended April 22, 2023
	Accumulated Other Comprehensive Loss		Retained Earnings		Total Stockholders' Equity
Sixteen Weeks As Previously Reported
Balance at December 31, 2022	$	(45,143)	$	4,744,624	$	2,678,281
Net income	—		42,651		42,651
Total other comprehensive income	788		—		788
Balance at April 22, 2023	$	(44,355)	$	4,697,697	$	2,636,161
Adjustments
Balance at December 31, 2022	$	448	$	(79,537)	$	(79,089)
Net income	—		5,672		5,672
Total other comprehensive income	(24)		—		(24)
Balance at April 22, 2023	$	424	$	(73,865)	$	(73,441)
As Corrected
Balance at December 31, 2022	$	(44,695)	$	4,665,087	$	2,599,192
Net income	—		48,323		48,323
Total other comprehensive income	764		—		764
Balance at April 22, 2023	$	(43,931)	$	4,623,832	$	2,562,720


Condensed Consolidated Statement of Cash Flows
Sixteen Weeks Ended April 22, 2023
	As Previously Reported		Adjustments		As Corrected
Net income	$	42,651	$	5,672	$	48,323
Other, net	391		458		849
Net change in:
Receivables, net	(83,370)		(2,457)		(85,827)
Inventories, net	(100,178)		(4,177)		(104,355)
Accounts payable	(440,995)		16,805		(424,190)
Accrued expenses	85,035		4,631		89,666
Other assets and liabilities, net	1,534		(24,591)		(23,057)
Net cash used in operating activities	(378,865)		(3,659)		(382,524)
Other, net (1)	(3,919)		(458)		(4,377)
Net cash used in financing activities	425,660		(458)		425,202
Effect of exchange rate changes on cash	93		(25)		68
Net (decrease) increase in cash and cash equivalents	(42,783)		(4,142)		(46,925)
Cash and cash equivalents, beginning of period	269,282		1,523		270,805
Cash and cash equivalents, end of period	$	226,499	$	(2,619)	$	223,880